DE STEFANO, NICOLA
 Distribuzione geografica
Continente #
NA - Nord America 34.647
EU - Europa 23.035
AS - Asia 12.956
SA - Sud America 2.678
AF - Africa 257
OC - Oceania 48
Continente sconosciuto - Info sul continente non disponibili 25
Totale 73.646
Nazione #
US - Stati Uniti d'America 34.357
GB - Regno Unito 6.286
CN - Cina 4.793
RU - Federazione Russa 4.364
SG - Singapore 3.814
IE - Irlanda 3.146
BR - Brasile 2.279
IT - Italia 2.192
UA - Ucraina 2.002
HK - Hong Kong 1.852
SE - Svezia 1.349
DE - Germania 1.163
FR - Francia 1.093
KR - Corea 848
FI - Finlandia 628
VN - Vietnam 616
IN - India 250
ES - Italia 168
NL - Olanda 164
AR - Argentina 151
TR - Turchia 132
CA - Canada 129
BD - Bangladesh 120
MX - Messico 97
BE - Belgio 89
AT - Austria 86
ZA - Sudafrica 83
IQ - Iraq 79
EC - Ecuador 69
JP - Giappone 63
PL - Polonia 63
CO - Colombia 46
PK - Pakistan 46
VE - Venezuela 39
ID - Indonesia 38
AU - Australia 37
MA - Marocco 37
CZ - Repubblica Ceca 33
IR - Iran 33
SA - Arabia Saudita 33
CL - Cile 32
CI - Costa d'Avorio 30
UZ - Uzbekistan 30
RO - Romania 29
IL - Israele 27
PY - Paraguay 27
PH - Filippine 26
MK - Macedonia 25
AE - Emirati Arabi Uniti 24
EU - Europa 23
EG - Egitto 21
KE - Kenya 19
CH - Svizzera 18
DZ - Algeria 18
JO - Giordania 18
RS - Serbia 18
TN - Tunisia 18
KZ - Kazakistan 17
PE - Perù 16
AZ - Azerbaigian 15
NP - Nepal 15
GR - Grecia 14
JM - Giamaica 14
LT - Lituania 14
BG - Bulgaria 13
UY - Uruguay 11
MD - Moldavia 10
NZ - Nuova Zelanda 10
DO - Repubblica Dominicana 9
HU - Ungheria 9
AL - Albania 7
NO - Norvegia 7
PT - Portogallo 7
SY - Repubblica araba siriana 7
TT - Trinidad e Tobago 7
HN - Honduras 6
LU - Lussemburgo 6
NG - Nigeria 6
PA - Panama 6
SN - Senegal 6
TH - Thailandia 6
AM - Armenia 5
BH - Bahrain 5
BN - Brunei Darussalam 5
BO - Bolivia 5
BY - Bielorussia 5
CR - Costa Rica 5
DK - Danimarca 5
MY - Malesia 5
OM - Oman 5
BB - Barbados 4
HR - Croazia 4
KG - Kirghizistan 4
LV - Lettonia 4
PS - Palestinian Territory 4
CG - Congo 3
EE - Estonia 3
ET - Etiopia 3
GA - Gabon 3
GT - Guatemala 3
Totale 73.588
Città #
Southend 5.637
Dallas 4.600
Fairfield 4.003
Dublin 3.132
Houston 3.051
Ashburn 2.263
Singapore 2.000
Chandler 1.954
Woodbridge 1.917
Jacksonville 1.656
Wilmington 1.585
Seattle 1.575
Cambridge 1.390
Menlo Park 1.283
Hong Kong 1.211
Beijing 1.121
Moscow 1.087
Santa Clara 1.055
Hefei 875
Seoul 842
Princeton 752
Ann Arbor 708
Nanjing 559
Siena 504
Los Angeles 342
The Dalles 331
Boardman 283
Milan 273
San Mateo 258
San Diego 216
Nanchang 211
São Paulo 209
Buffalo 204
Helsinki 201
New York 196
Council Bluffs 184
Ho Chi Minh City 169
Columbus 168
Shenyang 162
Munich 146
Hanoi 127
Florence 125
Málaga 117
Dong Ket 113
Norwalk 110
Tianjin 101
Bengaluru 95
Hebei 94
Changsha 91
London 91
Rome 88
Redondo Beach 83
Jiaxing 78
Lancaster 78
Kunming 77
Düsseldorf 76
Brussels 68
Dearborn 68
Shanghai 67
Rio de Janeiro 65
San Francisco 63
Jinan 62
Falls Church 61
Turku 59
Amsterdam 58
Belo Horizonte 57
Hangzhou 55
Guangzhou 53
Izmir 53
Lappeenranta 52
Warsaw 52
Vienna 51
Brooklyn 50
Brasília 49
Zhengzhou 49
Tokyo 48
Toronto 48
Chicago 47
Nuremberg 47
Stockholm 47
Johannesburg 46
Frankfurt am Main 44
Curitiba 42
Boston 37
Ningbo 36
Phoenix 36
Montreal 35
Chennai 34
Denver 34
Pisa 33
Baghdad 32
Mexico City 31
Abidjan 30
Campinas 29
Fremont 29
Orem 28
Atlanta 27
Lanzhou 27
Washington 27
Poplar 26
Totale 51.849
Nome #
Effect of fingolimod on diffuse brain tissue damage in relapsing-remitting multiple sclerosis patients 759
Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. 570
An atypical case of Creutzfeldt-Jakob disease mimicking frontotemporal dementia: genotypic influence and clinical implications 444
Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis 444
Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis 433
A novel NOTCH3 frameshift deletion and mitochondrial abnormalities in a patient with CADASIL 422
A new missense mutation in caveolin-3 gene causes rippling muscle disease. 380
A rare association of myasthenia gravis and mitochondrial myopathy: a clinical, biochemical and morphologic study of one case 348
A Rett syndrome MECP2 mutation that causes mental retardation in men 347
A new family with CADASIL: presentation of an homozygous patient and comparison with heterozigous phenotypes. 340
Hemodynamic evaluation of the optic nerve head in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. 336
Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment 334
Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: The VMCI-tuscany study 313
1H-MR Spectroscopy in Traumatic Brain Injury 307
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: Update on clinical, diagnostic, and management aspects 305
Appraisal of brain connectivity in radiologically isolated syndrome by modeling imaging measures 301
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes 285
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study 282
A human post-mortem brain model for the standardization of multi-centre MRI studies 279
The burden of microstructural damage modulates cortical activation in elderly subjects with MCI and leuko-araiosis. A DTI and fMRI study 273
Acute unilateral visual loss as the first symptom of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 268
A novel approach with “skeletonised MTR” measures tract-specific microstructural changes in early primary-progressive MS 266
The role of dentate nuclei in human oculomotor control: Insights from cerebrotendinous xanthomatosis 266
A case of ovarioleukodystrophy without elF2B mutations 265
[(11)C]PBR28 or [(18)F]PBR111 detect white matter inflammatory heterogeneity in multiple sclerosis 258
SIENA-XL for improving the assessment of gray and white matter volume changes on brain MRI 257
Diffuse brain damage in normal tension glaucoma 256
A semiautomatic method for multiple sclerosis lesion segmentation on Dual-Echo MR imaging: Application in a multicenter context 253
Systemic blood pressure profile in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 251
Clinical relevance of brain volume changes in patients with cerebrotendinous xanthomatosis 251
Clinical Course of Two Italian Siblings with Ataxia-Telangiectasia-Like Disorder. 247
Peak width of skeletonized mean diffusivity (PSMD) as marker of widespread white matter tissue damage in multiple sclerosis 246
Primary Progressive Multiple Sclerosis Evolving from Radiologically Isolated Syndrome 242
Gray matter atrophy cannot be fully explained by white matter damage in patients with MS 242
Cardiac autonomic nervous system and risk of arrhythmias in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). 239
Automated identification of brain new lesions in multiple sclerosis using subtraction images 239
Blood–brain barrier permeability in a patient with Labrune syndrome due to SNORD118 mutations 239
Cortical damage in brains of patients with adult-form of myotonic dystrophy type 1 and no or minimal MRI abnormalities 238
Toscana itaca (Italian CADASIL) registry: an implementable online database for CADASIL (Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy). 234
Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis 231
Association of MRI metrics and cognitive impairment in radiologically isolated syndromes 231
Chemical pathology of acute demyelinating lesions and its correlation with disability 230
Evidence of diffuse damage in frontal and occipital cortex in the brain of patients with post-traumatic stress disorder 230
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery. 228
Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis 227
The spectrum of magnetic resonance findings in cerebrotendinous xanthomatosis: redefinition and evidence of new markers of disease progression 227
Adult-onset Niemann-Pick type C disease: a clinical, neuroimaging and molecular genetic study 226
CADASIL and cerebrovascular diseases 225
Genetic leukoencephalopaties with unknown metabolic pathogenesis 225
Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1 images in multiple sclerosis 225
Relevance of brain lesion location to cognition in relapsing multiple sclerosis 225
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. 224
Acute metabolic brain changes following traumatic brain injury and their relevance to clinical severity and outcome. 223
Acute visual loss due to anterior ischemic optic neuropathy as first symptom in a patient with CADASIL 222
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome 222
A practical review of the neuropathology and neuroimaging of multiple sclerosis 220
Cortical lesions in radiologically isolated syndrome. 219
Assessing response to interferon-β in a multicenter dataset of patients with MS 219
Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets. 219
Pronounced structural and functional damage in early adult pediatric-onset multiple sclerosis with no or minimal clinical disability 219
Merosin positive congenital muscular dystrophy with severe involvement of the central nervous system 218
Structural and functional brain changes beyond visual system in patients with advanced glaucoma 218
Optic atrophy in Marinesco-Sjögren syndrome: an additional ocular feature. Report of three cases in two families 216
Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients 215
Serial KL-6 measurements in COVID-19 patients 215
Altered Large-Scale Brain Functional Connectivity in Ocular Hypertension 214
Long-term assessment of no evidence of disease activity in relapsing-remitting MS 213
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis 213
Fingolimod effect on brain volume loss independently contributes to its effect on disability 213
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 213
Right-to-left shunt in CADASIL patients: prevalence and correlation with clinical and MRI findings 212
Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study 212
A comparison of cognitive performances between multiple sclerosis patients with pediatric- versus adult onset disease 211
Vitamin E deficiency secondary to chronic intestinal malabsorption and effect of vitamin supplement: a case report 211
Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders 211
Structural and metabolic damage in brains of patients with SPG11-related spastic paraplegia as detected by quantitative MRI 211
Early changes of brain connectivity in primary open angle glaucoma 210
DTI-derived indexes of brain WM correlate with cognitive performance in vascular MCI and small-vessel disease. A TBSS study 209
A multicentre study of motor functional connectivity changes in patients with multiple sclerosis 209
Brain atrophy assessment in multiple sclerosis: importance and limitations 208
Impairment of muscle mitochondrial oxidative metabolism in McArdles's disease 208
2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis 207
Relationship between brain MRI lesion load and short-term disease evolution in non-disabling MS: A large-scale, multicentre study 207
MRI in Leber's hereditary optic neuropathy: the relationship to multiple sclerosis. 206
Early structural changes in individuals at risk of familial Alzheimer's disease. A volumetry and magnetization transfer MR imaging study 204
Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis 204
Pathogenesis of multiple sclerosis: Insights from molecular and metabolic imaging 203
Progression of regional grey matter atrophy in multiple sclerosis 203
The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS 203
A Novel Mutation in the Notch3 Gene in an Italian Family with CADASIL: Genetic and MRI Spectroscopic Findings 202
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies 201
Combined aerobic training and dichloroacetate improve exercise capacity and indices of aerobic metabolism in muscle cytochrome oxidase deficiency 200
Scoring treatment response in patients with relapsing multiple sclerosis 197
Plasma levels of asymmetric dimethylarginine (ADMA) in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarct and Leukoencephalopathy (CADASIL) 197
GABA: A new imaging biomarker of neurodegeneration in multiple sclerosis? 195
Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis 195
Twelve-year monitoring of a patient with megalencephalic leukoencephalopathy with subcortical cysts 194
Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. 193
Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. 192
Prominent brain axonal damage and functional reorganization in "pure" adrenomyeloneuropathy. 192
Totale 25.231
Categoria #
all - tutte 227.102
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 227.102


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215.464 0 0 0 0 0 847 865 1.253 772 536 701 490
2021/20225.254 333 718 429 298 259 203 316 174 264 528 663 1.069
2022/20236.907 437 358 820 999 695 1.432 113 632 830 176 257 158
2023/20244.219 228 129 336 134 120 1.199 1.510 148 27 64 48 276
2024/202511.415 313 541 794 1.169 1.053 464 392 815 836 579 1.170 3.289
2025/202617.202 2.181 4.068 3.782 2.551 4.088 532 0 0 0 0 0 0
Totale 74.503